Japan Lifeline boosts financial targets, cancels shares, changes directors

Japan Lifeline (TSE:7575) announced revisions to its medium-term management plan, including increased financial targets for the fiscal year ending March 31, 2028. The company now anticipates sales of JPY70.0 billion, up from JPY63.0 billion, and sales from new business areas are projected to reach JPY11.0 billion, an increase from JPY8.0 billion. Earnings per share are set to JPY145, up from JPY120. These revisions are supported by strategies involving structural heart therapeutic areas, PFA product development, global sales expansion, and OEM manufacturing.